Susquehanna International Group’s Tourmaline Bio TRML Stock Holding History

Susquehanna International Group’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,600	Closed	-$650K	–	13642
2025 Q3	$650K	Buy	+13,600	New	+$377K	﹤0.01%	8377
2025 Q2	–	Sell	-45,000	Closed	-$684K	–	13733
2025 Q1	$684K	Buy	+45,000	New	+$721K	﹤0.01%	8198
2024 Q2	–	Sell	-30,400	Closed	-$696K	–	13257
2024 Q1	$696K	Buy	+30,400	New	+$1.07M	﹤0.01%	7712

Susquehanna International Group's TRML Position: Q4 2025 in Review

Susquehanna International Group sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 60,649 shares — an estimated $2.9M sold.

Susquehanna International Group first reported a position in TRML in Q1 2022 and held it in 12 quarters. The position peaked at $2.9M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Susquehanna International Group reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Susquehanna International Group sold 60,649 Tourmaline Bio shares in Q4 2025, an estimated $2.9M.
Susquehanna International Group first reported a position in Tourmaline Bio in Q1 2022 and held it in 12 quarters.
Susquehanna International Group's Tourmaline Bio position peaked at $2.9M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.